Dengue infection

MG Guzman, DJ Gubler, A Izquierdo… - Nature reviews Disease …, 2016 - nature.com
Dengue is widespread throughout the tropics and local spatial variation in dengue virus
transmission is strongly influenced by rainfall, temperature, urbanization and distribution of …

Recent developments in recombinant protein–based dengue vaccines

NK Tripathi, A Shrivastava - Frontiers in immunology, 2018 - frontiersin.org
Recombinant proteins are gaining enormous importance these days due to their wide
application as biopharmaceutical products and proven safety record. Various recombinant …

Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics

X Zhang, Y Zhang, R Jia, M Wang, Z Yin, A Cheng - Veterinary research, 2021 - Springer
Flaviviruses are enveloped single positive-stranded RNA viruses. The capsid (C), a
structural protein of flavivirus, is dimeric and alpha-helical, with several special structural …

Dengue viruses and promising envelope protein domain III-based vaccines

H Fahimi, M Mohammadipour… - Applied microbiology …, 2018 - Springer
Dengue viruses are emerging mosquito-borne pathogens belonging to Flaviviridae family
which are transmitted to humans via the bites of infected mosquitoes Aedes aegypti and …

Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli

SC Araujo, LR Pereira, RPS Alves, R Andreata-Santos… - Vaccines, 2020 - mdpi.com
This article aims to review the present status of anti-flavivirus subunit vaccines, both those at
the experimental stage and those already available for clinical use. Aspects regarding …

The nucleocapsid protein of SARS-CoV-2, combined with ODN-39M, is a potential component for an intranasal bivalent vaccine with broader functionality

Y Lobaina, R Chen, E Suzarte, P Ai, V Huerta… - Viruses, 2024 - mdpi.com
Despite the rapid development of vaccines against COVID-19, they have important
limitations, such as safety issues, the scope of their efficacy, and the induction of mucosal …

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice

CY Chiang, CH Pan, MY Chen, CH Hsieh, JP Tsai… - Scientific reports, 2016 - nature.com
We developed a novel platform to express high levels of recombinant lipoproteins with
intrinsic adjuvant properties. Based on this technology, our group developed recombinant …

[HTML][HTML] Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates

SP McBurney, JE Sunshine, S Gabriel, JP Huynh… - Vaccine, 2016 - Elsevier
We describe the preclinical development of a dengue virus vaccine targeting the dengue
virus serotype 2 (DENV2) envelope domain III (EDIII). This study provides proof-of-principle …

Characterization of pathogenic trypanosomatidae by restriction endonuclease fingerprinting of kinetoplast DNA minicircles

CM Morel, L Simpson - 1980 - arca.fiocruz.br
A simple protocol was developed for the routine preparation of a kinetoplast DNA fraction
from trypanosomatids. The digestion of this DNA with selected restriction endonucleases …

Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice

I Valdes, L Gil, L Lazo, K Cobas, Y Romero, A Bruno… - Vaccine, 2023 - Elsevier
Zika virus infection continues to be a global concern for human health due to the high-risk
association of the disease with neurological disorders and microcephaly in newborn …